ORLANDO, Fla., May 16, 2016 /PRNewswire/ -- An aging population, increasing demand for generic drugs, and the increasing number of patent expirations are some of the factors fueling the growth of this industry. The global pharmaceutical market is projected to increase at a compound annual growth rate of 4-7% to 2018 and reach $1.3 trillion, according to industry experts, and emerging markets are developing into sources of significant growth.
What's more, a clear trend toward localization has been observed, where the majority of emerging market participants consider investment in local research, local development, and local manufacturing to be the most effective levers for commercial success in their respective regions.
The pharmaceutical and biotech factory (the project) provides an opportunity for low production costs given the high need for domestic product and low cost of natural resources in the country, and is strategically located in the heart of Eastern Europe with easy access to Western Europe and the Mediterranean.
The method by which this $8.4 million project is to be funded is the brainchild of Mr Herard. Mr Herard is a seasoned merchant banker and has been in the banking industry for 38 years. As the head of Capital Corp Merchant Banking, Mr Herard has become a leading figure in international middle-market project financing and engineers all funding structures for projects at Capital Corp. Mr Herard has received numerous awards for his work and other contributions including being appointed to the Presidential Business Commission, Honorary Co-Chairman of the Business Advisory Council, nominated as Executive of the Year by the internationally acclaimed National Register's Who's Who, and having received the Senatorial Medal of Freedom, among many others.
About Capital Corp Merchant Banking: Capital Corp Merchant Banking offers quality Merchant Banking services for a variety of projects worldwide. Capital Corp Merchant Banking has developed close working relationships with groups of Professionals: Specialists in Finance, Commercial Risks Insurance and Re-Insurance, International Accounting Firms and Law Firms, and the largest Valuation Firm in the world. Capital Corp Merchant Banking is solution-oriented and known for being the most flexible Funding Source on the Market in creating handcrafted investment structures to meet the needs of the different constituent groups in each individual transaction, including pharmaceutical and biotech projects. Capital Corp Merchant Banking offers many services: Project Financing, Business Debt Restructuring, Consulting, Negotiating Services, Acquisitions, and Investment Approach. For further information, please visit our website.
Press release distributed by PRLog
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmaceutical-factory-project-in-albania-obtains-84m-funding-agreement-from-capital-corp-merchant-banking-300269455.html
SOURCE Capital Corp Merchant Banking